| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.027 | 0.6 |